Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)

BACKGROUND: Intraductal carcinoma of the prostate (IDC-P) is a subtype of prostate cancer featured by poor prognosis. Previous studies suggested IDC-P could have a potentially unstable genome. Homologous recombination deficiency (HRD) score is a result-oriented method to describe the genomic instabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Sha, Zhao, Jinge, Nie, Ling, Yin, Wenlian, Zhang, Yaowen, Zhao, Fengnian, Ni, Yuchao, Zhang, Xingming, Wang, Zhipeng, Dai, Jindong, Liu, Zhenhua, Chen, Junru, Zeng, Yuhao, Wang, Zilin, Sun, Guangxi, Liang, Jiayu, Zhao, Xiaochen, Zhu, Xudong, Tao, Ronggui, Yang, Jiyu, He, Ben, Chen, Ni, Shen, Pengfei, Zeng, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306093/
https://www.ncbi.nlm.nih.gov/pubmed/35864546
http://dx.doi.org/10.1186/s12916-022-02430-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306093/
https://www.ncbi.nlm.nih.gov/pubmed/35864546
http://dx.doi.org/10.1186/s12916-022-02430-0

Ejemplares similares